Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details)

v3.23.3
NET LOSS PER SHARE - Outstanding potentially dilutive common shares (Details) - shares
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive securities excluded from computation of earnings per share    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 16,165,117 3,417,637
Options Issued and Outstanding under Stock Option Plan    
Antidilutive securities excluded from computation of earnings per share    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,041,492 689,321
Warrants    
Antidilutive securities excluded from computation of earnings per share    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 13,955,897 1,560,588
Series 1 Convertible Preferred Shares    
Antidilutive securities excluded from computation of earnings per share    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,166,667 1,166,667
Deferred Share Units    
Antidilutive securities excluded from computation of earnings per share    
Dilutive common shares equivalents excluded from computation of diluted net loss per share for periods presented because including them would have been antidilutive 1,061 1,061